Myotrophin in human heart failure

Journal of the American College of Cardiology

Volumn 42, Issue 4, 2003, Pages 719-725

  O'Brien, Russell J ^a   Loke, Ian ^a   Davies, Joan E ^a   Squire, Iain B ^a   Ng, Leong L ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RECOMBINANT SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENDER; GENETIC TRANSCRIPTION; HEART FAILURE; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOASSAY; SEX DIFFERENCE;

EID: 0042855662     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00755-1     Document Type: Article

References (13)

1. Sen S, Kundu G, Mekhail N, Castel J, Misono K, Healy B. Myotrophin: purification of a novel peptide from spontaneously hypertensive rat heart that influences myocardial growth. J Biol Chem 1990;265:16635-43.
2. Sil P, Misono K, Sen S. Myotrophin in human cardiomyopathic heart. Circ Res 1993;73:98-108.
3. Mukherjee DP, McTiernan CF, Sen S. Myotrophin induces early response genes and enhances cardiac gene expression. Hypertension 1993;21:142-8.
4. Sil P, Kandaswamy V, Sen S. Increased protein kinase C activity in myotrophin-induced myocyte growth. Circ Res 1998;82:1173-88.
5. Sivasubramanian N, Adhikary G, Sil PC, Sen S. Cardiac myotrophin exhibits rel/NF-kappa B interacting activity in vitro. J Biol Chem 1996;271:2812-6.
6. Knuefermann P, Chen P, Misra A, Shi SP, Abdellatif M, Sivasubramanian N. Myotrophin/V-1, a protein upregulated in the failing human heart and in postnatal cerebellum converts NFkappa B p50-p65 heterodimers to p50-p50 and p65-p65 homodimers. J Biol Chem 2002;277:23888-97.
7. Gupta S, Sen S. Myotrophin-kappaB DNA interaction in the initiation process of cardiac hypertrophy. Biochim Biophys Acta 2002;1589:247-60.
8. Wong SC, Fukuchi M, Melnyk P, Rodger I, Giaid A. Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. Circulation 1998;98:100-3.
9. Valen G, Yan ZQ, Hansson GK. Nuclear factor kappa-B and the heart. J Am Coll Cardiol 2001;38:307-14.
10. Anderson KM, Berrebi-Bertrand I, Kirkpatrick RB, et al. cDNA sequence and characterization of the gene that encodes human myotrophin/V-1 protein, a mediator of cardiac hypertrophy. J Mol Cell Cardiol 1999;31:705-19.
11. Talwar S, Downie PF, Squire IB, Barnett DB, Davies JE, Ng LL. An immunoluminometric assay for cardiotrophin-1: a newly identified cytokine is present in normal human plasma and is increased in heart failure. Biochem Biophys Res Commun 1999;261:567-71.
12. Ng LL, O'Brien RJ, Demme B, Jennings S. A non-competitive immunochemiluminometric assay for cardiotrophin-1 detects elevated plasma levels in human heart failure. Clin Sci 2002;102:411-6.
13. Rademaker MT, Charles CJ, Espiner EA, et al. Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep. J Am Coll Cardiol 2002;40:1495-505.